4don MSN
Over the past decade, early-stage drug innovation has shifted toward China, researchers find
Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a ...
A growing body of research has examined the IRA’s implications for pharmaceutical innovation. Much of this literature has focused on the potential impact on the number of new drug launches, 5, 6 but ...
When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.
Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
Christine Allen, CEO and Co-Founder of Intrepid Labs, and Andy Lewis, CSO at Quotient Sciences, highlight their strategic ...
From survivorship bias to root causes! Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening ...
Company announces the appointment of Pamela Vig, Ph.D., a seasoned rare disease drug development executive, to its Board of Directors ...
Tozorakimab met the primary goal in two late-stage clinical trials, reducing the rate at which patients’ symptoms worsened, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results